Samrat Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
200.15
-4.85 (-2.37%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 3.01 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "200.15",
    "chg": -4.85,
    "chgp": "-2.37%",
    "dir": -1,
    "prev_price": "205.00",
    "mcapval": "63.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE103E01016",
    "curr_date": "Jun 11, 03:30 PM",
    "curr_time": "19:39 PM",
    "last_traded_at": "Jun 11, 03:30 PM IST",
    "bse_nse_vol": "3.01 k",
    "exc_status": "Active",
    "traded_date": "Jun 11, 2026",
    "traded_date_str": "2026 06 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "116063",
    "stock_news_url": "https://www.marketsmojo.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Jun-2026",
      "details": "Newspaper Publication of Extract of the Standalone Audited Financial Results for the year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Quarter And Year Ended 31 March 2026",
      "datetime": "30-May-2026",
      "details": "Audited Financial Results for the quarter and year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
      "datetime": "30-May-2026",
      "details": "The Board considered and adopted the financial results for the quarter and year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

04-Jun-2026 | Source : BSE

Newspaper Publication of Extract of the Standalone Audited Financial Results for the year ended March 31 2026.

Audited Financial Results For The Quarter And Year Ended 31 March 2026

30-May-2026 | Source : BSE

Audited Financial Results for the quarter and year ended 31st March 2026

Board Meeting Outcome for Outcome Of The Board Meeting

30-May-2026 | Source : BSE

The Board considered and adopted the financial results for the quarter and year ended March 31 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Samrat Pharmachem Ltd has declared 10% dividend, ex-date: 18 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available